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MHC-restricted antigen recognition is mediated by a T cell receptor (TCR)
composed of a disulfide-linked heterodimer of the a and a chains and the
multicomponent T3 complex (1) . Recently, a second T3-associated putative TCR
heterodimer has been described on a subset of human PBL (2-4), thymocytes
(5), a leukemia line (6), and on a subset ofmurine thymocytes (7-9) . This second
TCR is composed of the protein products of rearranged TCR y-chain genes,
which are associated with a poorly characterized chain termed S . We have recently
demonstrated by immunofluorescent staining of epidermal sheets that a popula-
tion of Thy-I+ , bone marrow-derived, epidermal cells with a dendritic mor-
phology (Thy-1' DEC) express T3 and are also reactive with an antiserum to the
TCR y chain (10) .' Long-term IL-2-dependent cell lines derived from Thy-1'
DEC express a T3-associated 34 kD y chain that is frequently linked to a 46 kD
partner.
In the present report, we describe the initial characterization of a T cell
hybridoma derived from the fusion of a lymphokine-dependent long-term TCR
y/b+Thy-1 + DEC cell line with the BW5147 tumor line . The resultant hybridoma
is rapidly growing, lymphokine independent, expresses T3 in association with
the TCR y and b chains, and secretes IL-2 in response to stimulation with anti-
T3 and Con A .
Materials and Methods
Cell Lines.
￿
The conditions for the establishment and maintenance ofthe Thy-1' DEC
cell line, T245, have been described previously (10) . The HAT-sensitive BW5147 T cell
line was obtained from the American Type Culture collection (ATCC), Rockville, MD .
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The 2B4 T cell hybridoma, a BW5147 fusion product which expresses TCR a/,B (11),
was obtained from Dr.Jonathan Ashwell (NIH).
Production of T Cell Hybridomas.
￿
A 1:1 mixture ofT245 and BW5147 cells wasstirred
in 50% (wt/vol) PEG (E. Merck, Darmstadt, Federal Republic of Germany) for 2 min,
washed, and plated (2-4 X 105 cells/well) in 96-well Costar plates (Costar, Cambridge,
MA) containing 5 X 10' X-irradiated (3,000 rad) peritoneal "wash out" cells in 0.2 ml of
RPMI 1640 containing 20% FCS, HAT, L-glutamine, penicillin/streptomycin, 2-ME, and
Hepes buffer. After 11 d, hybridomas were picked, expanded, and tested for T3 expres-
sion by flow cytometry. Positive lines were cloned by limiting dilution (0.3 cells/well) in
96-well microtiter plates.
Antisera and mAbs.
￿
The properties ofmonoclonal hamsteranti-mouse T3 e antibody
(145-2C11, 12), rabbit antisera to the mouse T3 S chain (R9 kindly provided by Dr.
Lawrence Samelson, NIH) (13) and to the mouse TCR .y chain (7) have been previously
published.
Cell Surface Labeling, Immunoprecipitation, and SDS-PAGE.
￿
Cell surface labeling and
Immunoprecipitation were carried out as described previously (7, 14). Samples were
analyzed on 12% polyacrylamide slab gels under either nonreducing or reducing condi-
tions.
Assay of T Hybridomas for Activity.
￿
105 T hybridoma cells were cocultured with 10'
irradiated (10,000 rad) LS B lymphoma cells (15) or 105 irradiated (3,000 rad) anti-Thy-
1 .2 + C'-treated C3H spleen cells in 0.2 ml of medium in the presence of 145-2C11
culture supernatant (1:10 or 1:100, final dilution) or Con A (10,ug/ml). After 24-36 hof
culture, supernatants were collected and assayed for IL-2 content in a secondary culture
with CTLL cells as described previously (16). The degree of stimulation was assayed by
the incorporation of ['H]thymidine into DNA. Results are expressed as mean cpm
incorporated by triplicate cultures.
Results and Discussion
We have previously demonstrated that the Thy-1' DEC cell line, T245,
expresses no TCR a chain mRNA, the truncated (1.0 kb) form of the TCR a
chain mRNA, but abundant levels of normal-size TCR y chain mRNA (10).
Immunoprecipitation studies of surface-labeled cells with anti-T3 S chain and
anti-TCR y chain antisera revealed a 34 kD y chain that was disulfide linked to
a 46 kD S chain partner. However, further structural and functional studies of
the TCR y/b complex on the surface of T245 cells were hampered because of
the slow in vitro growth of this cell line, which is dependent on high concentra-
tions of Con A-stimulated rat spleen cell supernatants. We therefore immorta-
lized this cell line by fusing it to the T3- BW5147 tumor line and selecting for
positive growth in the presence of HAT and in the absence of lymphokines.
Growing wells were then screened for surface T3 expression by reactivity with
anti-T3 mAb (145-2C11) and flow cytometry. Hybridomas of interest were
subcloned by limiting dilution and subjected to further analysis. Flow cytometric
analysis also revealed that the hybridomas displayed uniform reactivity with both
an anti-Thy-1 .1 mAb and an anti-Thy-1 .2 mAb, whereas these Thy-1 alleles are
independently expressed on the AKR-derived BW5147 and C3H-derived T245
parent cell lines, respectively . All hybridoma lines were also L3T4-, Ly-2-, and
la (data not shown).
To analyze the biochemical properties of the T3-associated heterodimer on
the hybridomas, the parental cell lines, several T3+ hybridomas and one T3-
hybridoma (2G8) were cell surface-radioiodinated and specific immunoprecipi-
tations were performed. No specific bands were seen when lysates of BW5147
or 2G8 were subjected to Immunoprecipitation with the anti-T3 6 chain anti-YOKOYAMA ET AL .
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FIGURE 2.
￿
Analysis ofTCR y chain expression by the 1 C6 cell line .
IC6 cells were surface iodinated, lysed in 1% NP-40, and specific
immunoprecipitations were carried out. Lane 1, normal rabbit serum ;
lane 2, anti-TCR .y antiserum .
serum (Fig . 1,A and B) . As previously shown,' the T245 cell line expressed a
T3-associated 80-90 kD molecule under nonreducingconditions (Fig . 1 A), which
was composed of 34 and 46 kD chains under reducing conditions (Fig . 1B) . All
three T3' (1 C6, 1A5, and 1G9) hybridomas expressed a 34-46 kD heterodimer
that had the same mobility as that detected on T245 (Fig . 1B) .A similar complex
was seen when immunoprecipitations were performed with the anti-T3 e chain
mAb 145-2C 11 on lysates from the 1C6 hybridoma line (Fig . 1,A and B; IC6,
lane 3) . The 34-46 kD bands were also immunoprecipitated by the anti-TCR 'Y
serum as shown in Fig . 2 for the lC6 hybridoma proving that these hybridomas
expressed the TCR y/6 chains . Furthermore, the 34 kD band is the TCR -f
chain, because in T245 lysates this chain has previously been demonstrated to
react specifically with the anti-y antiserum.' It should be noted thatan additional
band (^-90 kD) is seen under nonreducing conditions in the immunoprecipitates
of all three hybridoma lines that is not present in the precipitates of the T245
cell line (Fig . 1 A) . It is unlikely that this higher-molecular-mass band is composed
of the TCR «/Q chains because no chains with the mobilities of the TCR a/0
chains are seen in the reducing gel (Fig . IB) . More detailed biochemical and
molecular studies will be required to elucidate the origin of this molecular
species.
To determine whether signal transduction may occur through the TCR y/6-
T3 complex, the parental lines as well as two subclones of the T3' 1C6 cell line
(1C6.F 11 and 1C6.H 10), andone subclone of the T3-T cell hybridoma (2G8 .E8)
were tested for their ability to produce IL-2 in response to stimulation with the
anti-T3 mAb or the mitogen Con A . No IL-2 production was seen following
stimulation of BW5147, T245, or the T3- hybridoma 2G8 with either Con A
or anti-T3 (Table 1) . In contrast, both of T3*, TCR y/6' hybridomas and theExp.
YOKOYAMA ET AL .
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TABLE I
IL-2 Production by TCR y/b+ TCell Hybridoms
Summary
* 10'T cells were cocultured for 2 d with 10'LS Blymphoma cells (Exp . I)or 10' T-depleted C3H spleen cells (Exp . II) in
the presence ofCon Aor 145-2C I I supernatant in 0.2 ml of medium . The primary culture supernatants were assayed
for IL-2 content by culturing 5 x 103 CTLL cells for 36 h in the presence of 25% primary culture supernatants . The
degree of stimulation was measured by the incorporation of [sH]thymidine into DNA during the final 18 h . Data are
expressed as mean cpm of triplicate cultures.
T3+, TCR a/,8+ hybridoma 2114 produced easily detectable levels of IL-2 after
Con A or anti-T3 stimulation . These results are consistent with the previously
described anti-T3 stimulation of an uncloned murine thymocyte subpopulation
(8) and a cloned human T cell line (5), both ofwhich bear the TCR 'y/b .
The availability of large numbers of cloned T hybridoma cells that express the
TCR y/b heterodimer should greatly facilitate the dissection of the role of this
receptor in T lymphocyte development and function . These factor-independent
lines should also prove to be useful in obtaining sufficient quantities of the TCR
b chain for further biochemical and molecular studies, as well as for the produc-
tion ofmAbs and heteroantisera . Further comparative studies of the makeup of
the T3 complex in TCR a/,Q lines and TCR y/b lines may also prove to be of
interest . Because we have no evidence for TCR a/ I# on the TCR y/b T cell
hybridoma, our studies strongly suggest that the TCR y/6-T3 complex can
function in a manner identical to that of the TCR a/,#-T3 complex in signal
transduction for IL-2 production in response to Con A and anti-T3 . Further
studies of the responsiveness of these cloned hybridoma lines to a wide variety
of soluble as well as cell associated stimuli are in progress .
We have produced a T cell hybridoma line by fusion ofan IL-2-dependent,
long-term T cell receptor (TCR) y/b+ Thy-1', bone marrow-derived, dendritic
epidermal cell line to the BW5147 tumor line . The resultant hybridoma was
rapidly growing, lymphokine independent, and expressed T3 in association with
the TCR y/b heterodimer . Several subclones of the hybridoma line produced
easily detectable levels of IL-2 after stimulation by anti-T3 or Con A . The
availability of these cloned cell lines should greatly facilitate further functional,
biochemical, and molecular studies of the TCR b chain .
We thank Dr . Jonathan Ashwell for providing the 2114 hybridoma, Dr . Lawrence Samelson
for providing the R9 antiserum, Mr . Robert Valas for expert technical assistance, and Ms.
Shirley Starnes for expert manuscript preparation .
Stimulus
BW5147 T245
[sH]TdR
IC6.F11
incorporation*
1C6.H10 2G8.E8 2B4
cPm
Media 2,779 1,687 1,141 1,164 1,171 1,187
Con A, 10,ug/ml 2,989 2,632 89,664 70,858 1,171 44,746
145-2C11, 1/10 1,865 1,973 41,062 31,080 1,154 95,520
145-2C11, 1/100 1,419 1,860 31,914 16,022 707 46,799
Media 706 ND 561 439 417 ND
Con A, 10 kg/ml 1,355 31,735 19,861 899
145-2C11, 1/10 834 13,539 7,051 759
145-2C11, 1/100 484 10,611 4,421 3411730
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